Gene · 79679
NIH grants878
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 878
Download this page as JSON| Grant | Title | VTCN1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA212424 | Role of the histone modifier MLL3 mutation in breast cancer cell plasticity | 1 | 2024 |
| R01CA229618 | Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy | 1 | 2024 |
| R01CA235667 | A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma | 1 | 2024 |
| R01CA238263 | The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity | 1 | 2024 |
| R01CA243547 | Impact of mutation burden on cancer growth and the immune landscape | 1 | 2024 |
| R01CA245323 | Mechanisms and therapeutic targets of cancer metastasis | 1 | 2024 |
| R01CA247666 | Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy | 1 | 2024 |
| R01CA248430 | Metabolic impact on T cell-mediated cancer immunity and therapy | 1 | 2024 |
| R01CA251608 | A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously | 1 | 2024 |
| R01DK126444 | iPLA2beta-mediated alternative splicing and beta-cell death in type 1 diabetes | 1 | 2024 |
| R01ES031253 | Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | 1 | 2024 |
| R01NS114653 | Endoplasmic Reticulum Stress Responses in Pain | 1 | 2024 |
| R01NS115403 | Role of Protein Methylation in Cell Mitosis and Glioblastoma | 1 | 2024 |
| R01NS117104 | Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma | 1 | 2024 |
| R37CA214955 | Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade Gliomas | 1 | 2024 |
| R37CA215436 | A novel more effective genotoxic therapy for ovarian cancer | 1 | 2024 |
| R50CA243707 | Single Cell Spatial Analysis in Tissue | 1 | 2024 |
| T32CA009666 | Research Training in Academic Medical Oncology | 1 | 2024 |
| T32CA200561 | Training of Surgeon Scientists in Basic and Translational Cancer Research | 1 | 2024 |
| T32CA251072 | Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan) | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/grants?page=11